Nice to see director buying Dr Elliott doubling her holding on market trades (38k purchase for context)
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Name of entity PolyNovo Limited ABN 96 083 866 862
Introduced 30/09/01 Amended 01/01/11
Appendix 3Y Change of Director’s Interest Notice
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director Dr Robyn Elliott Date of last notice 30 June 2023
Part 1 - Change of director’s relevant interests in securities
Direct N/A
31 October 2023
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Direct or indirect interest
No. of securities held prior to change
Class
Number acquired by Dr Elliot Number disposed
42,789 ordinary fully paid shares
Nature of indirect interest
Note: Provide details of the circumstances giving rise to the relevant interest.
(including registered holder)
Date of change
Ordinary fully paid shares.
32,000 ordinary fully paid shares.
Nil.
Note: If consideration is non-cash, provide details and estimated valuation
No. of securities held after change
$38,080.00 paid by Dr Elliott to acquire 32,000 shares at $1.19 per share via on market trade.
Value/Consideration
Across all holdings:
74,789 fully paid ordinary shares.
+ See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
ME_206737525_4
Appendix 3Y
Change of Director’s Interest Notice
Shares acquired via on-market trade.
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back
Nature of change
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract N/A Nature of interest N/A
Name of registered holder N/A (if issued securities)
Date of change N/A N/A
No. and class of securities to which
Note: Details are only required for a contract in relation to which the interest has changed
interest related prior to change
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change N/A Part 3 – +Closed period
Were the interests in the securities or contracts detailed No above traded during a +closed period where prior written clearance was required?
If so, was prior written clearance provided to allow the N/A trade to proceed during this period?
If prior written clearance was provided, on what date was N/A this provided?
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
ME_206737525_4
